Your search history is turned on.
Date: March 5, 2012 Jurisdictions: British Columbia
Microsoft Word - BCF 51-509F1 March 5, 2012.doc BC Form 51-509F1 Notice OTC Issuer Ceases to be an OTC Reporting Issuer This is the form required under section 4(1) of BC Instrument 51-509 Issuers Quoted in the U.S. Over-the-Counter Markets for an OTC issuer to give notice that it is no longer an OTC reporting issuer. The Issuer Name of Issuer:...
Date: February 8, 2012 Jurisdictions: British Columbia
http://www.sec.gov/Archives/edgar/data/1368620/000125529412000015/mainbody.htm 10-Q 1 mainbody.htm MAINBODY UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q [X] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended November 30, 2011 [ ] Transition Repor...
http://www.sec.gov/Archives/edgar/data/1368620/000125529412000015/mainbody.htm Table of Contents PART I - FINANCIAL INFORMATION Item 1. Financial Statements Our financial statements included in this Form 10-Q are as follows: F-1 Condensed Balance Sheet as of November 30, 2011 and February 28, 2011 (unaudited) F-2 Condensed Statements of Operations ...
http://www.sec.gov/Archives/edgar/data/1368620/000125529412000015/ex31_2.htm EX-31.2 3 ex31_2.htm CERTIFICATIONS I, Kristian Schiorring, certify that; 1. I have reviewed this quarterly report on Form 10-Q for the quarter ended November 30, 2011 of Bioflamex Corporation (the registrant); 2. Based on my knowledge, this report does not contain any untrue state...
http://www.sec.gov/Archives/edgar/data/1368620/000125529412000015/ex31_1.htm EX-31.1 2 ex31_1.htm CERTIFICATIONS I, Kristian Schiorring, certify that; 1. I have reviewed this quarterly report on Form 10-Q for the quarter ended November 30, 2011 of Bioflamex Corporation (the registrant); 2. Based on my knowledge, this report does not contain any untrue state...
Microsoft Word - BCF 51-509F1 _1_.DOC BC Form 51-509F1 Notice OTC Issuer Ceases to be an OTC Reporting Issuer This is the form required under section 4(1) of BC Instrument 51-509 Issuers Quoted in the U.S. Over-the-Counter Markets for an OTC issuer to give notice that it is no longer an OTC reporting issuer. The Issuer Name of Issuer: Bioflamex...
Date: November 3, 2011 Jurisdictions: British Columbia
http://www.sec.gov/Archives/edgar/data/1368620/000125529411000594/mainbody.htm 10-Q 1 mainbody.htm MAINBODUY UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q [X] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended August 31, 2011 [ ] Transition Report purs...
http://www.sec.gov/Archives/edgar/data/1368620/000125529411000594/mainbody.htm Table of Contents PART I - FINANCIAL INFORMATION Item 1. Financial Statements Our financial statements included in this Form 10-Q are as follows: F-1 Balance Sheet as of August 31, 2011 and February 28, 2011 (unaudited); F-2 Statements of Operations for the three and six months end...
http://www.sec.gov/Archives/edgar/data/1368620/000125529411000594/ex31_2.htm EX-31.2 3 ex31_2.htm EXHIBIT 31.2 CERTIFICATIONS I, Kristian Schiorring, certify that; 1. I have reviewed this quarterly report on Form 10-Q for the quarter ended August 31, 2011 of Bioflamex Corp (the registrant); 2. Based on my knowledge, this report does not contain any untrue s...
http://www.sec.gov/Archives/edgar/data/1368620/000125529411000594/ex31_1.htm EX-31.1 2 ex31_1.htm EXHIBIT 31.1 CERTIFICATIONS I, Kristian Schiorring, certify that; 1. I have reviewed this quarterly report on Form 10-Q for the quarter ended August 31, 2011 of Bioflamex Corp (the registrant); 2. Based on my knowledge, this report does not contain any untrue s...